Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 1 Immunoglobulin Light-chain Amyloidosis 1 Essential Hypertension 1 Breast Neoplasms 1

Interventions

Dexamethasone 50 Melphalan 29 Cyclophosphamide 25 Bortezomib 24 Filgrastim 18 Calcium Dobesilate 18 Peripheral Blood Stem Cell Transplantation 16 daratumumab 13 pomalidomide 10 dexamethasone acetate 8 Lenalidomide 8 fludarabine phosphate 7 ixazomib 6 dexamethasone 21-phosphate 6 Whole-Body Irradiation 6 Mycophenolic Acid 6 venetoclax 5 birtamimab 5 auricularum 5 Thalidomide 5 Granulocyte Colony-Stimulating Factor 5 Cyclosporine 5 Busulfan 5 Radiotherapy 4 Interferon-alpha 4 Etoposide 4 Carboplatin 4 Biopsy 4 sargramostim 3 miridesap 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Immunoglobulin Light-chain Amyloidosis × Diuretics × Clear all

NCT01511263 2018-03-21

EpiCardiAL

Fondazione IRCCS Policlinico San Matteo di Pavia

Phase 2 Terminated

Immunoglobulin Light-chain Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡